Christine Grady nurse-bioethicist and researcher
Grady, Christine
Grady, Christine, 1960-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 41074643 ( Personal )
Permalink: http://viaf.org/viaf/41074643
Preferred Forms
-
100 0 _
‡a
Christine Grady
‡c
nurse-bioethicist and researcher
-
100 1 _ ‡a Grady, Christine
-
100 1 _
‡a
Grady, Christine
-
100 1 _
‡a
Grady, Christine
-
100 1 _ ‡a Grady, Christine
-
100 1 _
‡a
Grady, Christine
-
100 1 _ ‡a Grady, Christine
-
100 1 _
‡a
Grady, Christine,
‡d
1960-....
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| The ethics of placebo-controlled trials: methodological justifications |
|
| The Ethics of Studying Financial Incentives in Public Health Implementation: Study Design Challenges. |
|
| The ethics of uninsured participants accessing healthcare in biomedical research: A literature review |
|
| Everyday ethics: ethical issues and stress in nursing practice |
|
| Exploring decision-making of HIV-infected Hispanics and African Americans participating in clinical trials |
|
| FACTORS ASSOCIATED WITH WOMEN'S HEALTH CARE DECISION-MAKING AUTONOMY: EMPIRICAL EVIDENCE FROM NIGERIA. |
|
| How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question |
|
| The impact of ethics and work-related factors on nurse practitioners' and physician assistants' views on quality of primary healthcare in the United States |
|
| In memoriam: Alan Wertheimer. |
|
| Including persons with HIV infection in cancer clinical trials |
|
| Informed consent and patient registry for the rare disease community: Editorial |
|
| Informing egg donors of the potential for embryonic research: a survey of consent forms from U.S. in vitro fertilization clinics |
|
| Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials |
|
| Institutional Review Boards: Purpose and Challenges |
|
| Introduction: the Fogarty International Research Ethics Education and Curriculum Development Program in historical context |
|
| The invisible hand in clinical research: the study coordinator's critical role in human subjects protection |
|
| Is It Ethical to Use Genealogy Data to Solve Crimes? |
|
| The limitations of "vulnerability" as a protection for human research participants. |
|
| The limits of disclosure: what research subjects want to know about investigator financial interests. |
|
| Making the Choices Necessary to Make a Difference: The Responsibility of National Bioethics Commissions |
|
| Making the transition to a learning health care system. Commentary. |
|
| Misconceptions about coercion and undue influence: reflections on the views of IRB members |
|
| The misguided ethics of crossover trials |
|
| Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism |
|
| Moral distress in the health professions |
|
| More than the money: a review of the literature examining healthy volunteer motivations |
|
| Motivations and decision-making of adult sickle cell patients in high-risk clinical research |
|
| Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research |
|
| Neuroethics in the Age of Brain Projects. |
|
| The NIH BRAIN Initiative: Integrating Neuroethics and Neuroscience |
|
| Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation |
|
| Nurses and COVID-19: Ethical Considerations in Pandemic Care |
|
| Nurses and Industry: Conflict or Collaboration? |
|
| Nurses confronting the coronavirus: Challenges met and lessons learned to date |
|
| The nursing shortage and the quality of care |
|
| Oversight of human participants research: identifying problems to evaluate reform proposals |
|
| Palliative care: a supportive adjunct to pediatric phase I clinical trials for anticancer agents? |
|
| Patient and Family Descriptions of Ethical Concerns |
|
| Patients' decision-making process regarding participation in phase I oncology research. |
|
| Paying research subjects: an analysis of current policies |
|
| Perceptions of appropriateness of care in the intensive care unit. |
|
| Personal and community benefits and harms of research: views from Rakai, Uganda |
|
| Phase 1 healthy volunteer willingness to participate and enrollment preferences |
|
| Points to consider: The research ethics consultation service and the IRB |
|
| Post-trial Access to Tested Interventions: The Views of IRB/REC Chair, Investigators, and Research Participants in a Multinational HIV/AIDS Study |
|
| Post-trial responsibilities beyond post-trial access |
|
| Predictors of ethical stress, moral action and job satisfaction in health care social workers. |
|
| Quality improvement and ethical oversight |
|
| The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries |
|
| Quality of parental consent in a Ugandan malaria study |
|
| Randomization to standard and concise informed consent forms: development of evidence-based consent practices |
|
| Reciprocity and post-trial access for participants in antiretroviral therapy trials. |
|
| Reflections on two decades of bioethics: where we have been and where we are going |
|
| Reframing Consent for Clinical Research: A Function-Based Approach. |
|
| Research into a functional cure for HIV in neonates: the need for ethical foresight |
|
| Research involving pediatric stem cell donors: A way forward |
|
| Research mentors: an understated value? |
|
| Research on stored biological samples: the views of Ugandans. |
|
| Research on very early ART in neonates at risk of HIV infection. |
|
| Research vulnerability and patient advocacy: balance-seeking perspectives for the clinical nurse scientist? |
|
| Respondent burden in clinical research: when are we asking too much of subjects? |
|
| Response to "Nurses at the Table: Nursing, Ethics, and Health Policy". |
|
| Response to Open Peer Commentaries on “A Broader Understanding of Moral Distress” |
|
| Response to Peer Commentary on “Does Ethics Education Influence the Moral Action of Practicing Nurses and Social Workers?” |
|
| Risks and benefits of phase 1 oncology trials, 1991 through 2002. |
|
| Science, technology, and innovation: nursing responsibilities in clinical research |
|
| The search for an AIDS vaccine, 1995 : |
|
| SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus |
|
| So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development |
|
| Surgical medicine: imperfect and extraordinary. |
|
| A systematic review of the empirical literature evaluating IRBs: what we know and what we still need to learn |
|
| Thinking further about value: commentary on "A taxonomy of value in clinical research". |
|
| To friend or not to friend: the use of social media in clinical oncology |
|
| Views of adolescents and parents on pediatric research without the potential for clinical benefit |
|
| What makes clinical research in developing countries ethical? The benchmarks of ethical research. |
|
| What should research participants understand to understand they are participants in research? |
|
| When to start ART in Africa. |
|
| Why patients continue to participate in clinical research. |
|
| Women's autonomy in health care decision-making in developing countries: a synthesis of the literature |
|
| Zika Virus: Promoting Male Involvement in the Health of Women and Families |
|
